Nath Bio-Genes (India) Ltd (NATHBIOGEN) — shareholding pattern, promoter holding, financials and share price
About Nath Bio-Genes (India) Ltd (NATHBIOGEN)
Nath Bio-Genes (India) Ltd operates in the Other Agricultural Products industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as NATHBIOGEN and on the BSE under scrip code 537291. Its ISIN is INE448G01010.
Incorporated in 1993, Nath Bio-Genes Ltd is in the business of Production, Processing, and Marketing of Hybrid and GM Seeds [1]
Nath Bio-Genes (India) Limited develops, produces, processes and markets hybrid and GM seeds across field crops and vegetables, and sells plant nutrient supplements; it operates ten processing plants, cold-storage and conditioning facilities, multiple R&D stations and a pan-India distribution network of approximately 20,000 distributors and dealers spanning 23 states.
Recent financial momentum shows a strong top-line rebound with Q3FY26 revenue at ₹660 million (79% YoY) and 9MFY26 revenue of ₹3,859 million (23% YoY), while gross profit and PAT expanded year-on-year; however the company reported compressed EBITDA margins in Q3 and mixed margin signals across nine months, requiring scrutiny of cost and mix drivers.
Listed peers in Other Agricultural Products: Aelea Commodities Ltd, Prime Fresh Ltd, Tierra Agrotech Ltd, Sayaji Industries Ltd, C K K Retail Mart Ltd, BharatRohan Airborne Innovations Ltd.
Valuation & Returns
10 Jul 2026At ₹163.55 a share on 10 Jul 2026, Nath Bio-Genes (India) Ltd (NATHBIOGEN) was valued at a price-to-earnings ratio of 7.47x against an industry P/E of 33.81x and a price-to-book of 0.48x on a book value of ₹339.08 per share as of Mar 2025. Solomo computes return on equity of 6.46% and return on capital employed of 8.12% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 7.47x
- Industry P/E
- 33.81x
- P/B
- 0.48x
- EPS (TTM)
- ₹21.91
- Book value / share
- ₹339.08
- ROE
- 6.46%
- ROCE
- 8.12%
- ROA
- 4.06%
- Debt / equity
- 0.19x
- Dividend yield
- 1.22%
- EBITDA margin
- 15.35%
- 52-week range
- ₹162.2 – ₹165.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Nath Bio-Genes (India) Ltd (NATHBIOGEN) reported revenue of ₹445 crore, net profit of ₹42 crore and earnings per share of ₹21.91. That compares with revenue of ₹268 crore and net profit of ₹39 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹51.59 crore and net profit ₹-0.01 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 230 | 234 | 248 | 268 | 445 |
| Net profit (₹ cr) | -67 | 35 | 40 | 39 | 42 |
| EPS (₹) | -35.46 | 18.43 | 20.85 | 20.31 | 21.91 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 9.35% | 5.30% | 9.18% | 9.71% |
| Profit growth | 12.88% | -3.55% | - | -2.57% |
| Stock price CAGR | 5% | -16% | -9% | -20% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 45.6% of Nath Bio-Genes (India) Ltd (NATHBIOGEN) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.27% and domestic institutional investors (DII) hold 0.01%. Promoters have pledged 13.8% of their holding. Market capitalisation was ₹311 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2013.
Largest disclosed public shareholders in Jun 2026: MAYO FARMS LLP 5.72%, TAPOVAN FARMS LLP 5.09%, SEETHA KUMARI 2.79%, SATPAL KHATTAR 2.1%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 45.6% | 13.8% | 0.27% | 0.01% | 54.4% |
| Mar 2026 | 45.6% | 13.8% | 0.23% | 0.01% | 54.4% |
| Dec 2025 | 45.6% | 13.8% | 0.31% | 0.01% | 54.4% |
| Sep 2025 | 45.6% | 13.8% | 0.32% | 0.76% | 54.4% |
| Jun 2025 | 45.6% | 13.8% | 0.42% | 2.25% | 54.4% |
| Mar 2025 | 45.6% | 16.4% | 0.21% | 3.94% | 54.4% |
| Dec 2024 | 45.6% | 16.4% | 0.19% | 4.37% | 54.4% |
| Sep 2024 | 45.6% | 16.4% | 0.19% | 4.37% | 54.4% |